Bangor Savings Bank’s Cognition Therapeutics CGTX Stock Holding History

Bangor Savings Bank’s Portfolio CGTX Stock Details CGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$46.6K	Buy	40,519 +6,500	+19%	+$7.69K	﹤0.01%	301
2026 Q1	$25.8K	Hold	34,019	–	–	﹤0.01%	350
2025 Q4	$45.9K	Hold	34,019	–	–	﹤0.01%	302
2025 Q3	$45.9K	Hold	34,019	–	–	﹤0.01%	305
2025 Q2	$10.5K	Hold	34,019	–	–	﹤0.01%	417
2025 Q1	$14.3K	Hold	34,019	–	–	﹤0.01%	397
2024 Q4	$23.9K	Hold	34,019	–	–	﹤0.01%	362
2024 Q3	$15.9K	Hold	34,019	–	–	﹤0.01%	389
2024 Q2	$56.5K	Buy	34,019 +10,000	+42%	+$19.9K	0.01%	280
2024 Q1	$43.7K	Hold	24,019	–	–	﹤0.01%	302
2023 Q4	$44.4K	Hold	24,019	–	–	﹤0.01%	306
2023 Q3	$34.6K	Hold	24,019	–	–	﹤0.01%	319
2023 Q2	$44K	Buy	24,019 +5,000	+26%	+$10.6K	0.01%	308
2023 Q1	$37.7K	Hold	19,019	–	–	﹤0.01%	325
2022 Q4	$40K	Hold	19,019	–	–	﹤0.01%	319
2022 Q3	$36K	Hold	19,019	–	–	﹤0.01%	324
2022 Q2	$40K	Buy	19,019 +523	+3%	+$1.35K	﹤0.01%	317
2022 Q1	$51K	Buy	+18,496	New	+$71.3K	0.01%	178

Other funds holding CGTX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

EWM

Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

BIA

Barry Investment Advisors New Bedford, Massachusetts $478M AUM 23.65% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

Bangor Savings Bank's CGTX Position: Q2 2026 in Review

Bangor Savings Bank increased its Cognition Therapeutics (CGTX) stake by 19% in Q2 2026, buying an estimated $7.69K and bringing the position to 40,519 shares worth $46.6K. The position accounts for ﹤0.01% of the portfolio, ranked #301.

Bangor Savings Bank first reported a position in CGTX in Q1 2022 and has held it in 18 quarters since. The position peaked at $56.5K in Q2 2024. 6 funds tracked by Wall St. Rank hold CGTX as of Q2 2026.

Bangor Savings Bank held 40,519 shares of Cognition Therapeutics worth $46.6K as of Q2 2026.
Bangor Savings Bank bought 6,500 Cognition Therapeutics shares in Q2 2026, an estimated $7.69K.
Cognition Therapeutics made up ﹤0.01% of Bangor Savings Bank's portfolio in Q2 2026, its #301 holding.
Bangor Savings Bank first reported a position in Cognition Therapeutics in Q1 2022 and has held it in 18 quarters since.
Bangor Savings Bank's Cognition Therapeutics position peaked at $56.5K in Q2 2024.
6 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q2 2026.

Based on Bangor Savings Bank's 13F filing for Q2 2026, filed 6 Jul 2026.